MCRB
Closed
Seres Therapeutics Inc
10.705
-0.405 (-3.65%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 11.11
Day's Range: 9.8006 - 11.11
Send
sign up or login to leave a comment!
When Written:
5.67
Seres Therapeutics Inc is a biotechnology company that develops microbiome therapeutics. The company's lead product candidate, SER-109, is being developed for the treatment of recurrent Clostridioides difficile infection (CDI). The company's microbiome therapeutics platform is based on the understanding that the human microbiome plays a critical role in human health and disease. Seres Therapeutics Inc was founded in 2010 and is headquartered in Cambridge, Massachusetts. The company is publicly traded on the NASDAQ under the ticker symbol MCRB.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








